Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Volume 17 - Issue 7 - July, 2005

Column

Editorial Message
Editor`s Message
08/01/2008
Richard E. Shaw, PhD, FACC
Richard E. Shaw, PhD, FACC
Dear Readers, This issue of the Journal of Invasive Cardiology includes original research articles, case reports, case reports with reviews of the literature, editorials, and articles from the some of the journal’s special sections. In the...
Dear Readers, This issue of the Journal of Invasive Cardiology includes original research articles, case reports, case reports with reviews of the literature, editorials, and articles from the some of the journal’s special sections. In the...
Dear Readers, This issue of the...
08/01/2008
Journal of Invasive Cardiology
Feature
The Efficacy of Sirolimus-eluting Stents Versus Bare Metal Stents in Diabetic Patients Undergoing Elective Percutaneous Coronary
08/01/2008
Jiro Aoki, MD, Andrew Ong, MBBS, FRACP, Gaston Rodriguez-Granillo, MD, Carlos vanMieghem, MD, Joost Daemen, Karel Sonnenschein, Eugene McFadden, MBChB, FRCPI, Georgios Sianos, MD, PhD, Willem van der Giessen, MD, PhD, Pim de Feyter, MD, PhD, Ron van Domburg, PhD, Patrick Serruys, MD, PhD
Jiro Aoki, MD, Andrew Ong, MBBS, FRA...
Several clinical studies have demonstrated that diabetes mellitus is an important predictor of angiographic restenosis and late mortality after conventional balloon angioplasty.1,2 Stent implantation has been shown to improve the clinical...
Several clinical studies have demonstrated that diabetes mellitus is an important predictor of angiographic restenosis and late mortality after conventional balloon angioplasty.1,2 Stent implantation has been shown to improve the clinical...
Several clinical studies have...
08/01/2008
Journal of Invasive Cardiology
Safety and Efficacy of a New Filter-based Protection System for Aorto-Coronary Bypass Graft Interventions: The ev3 Spider‚Ñ¢ Devic
08/01/2008
Hubertus von Korn, MD, Jiangtao Yu, MD, Burckhard Huegl, MD, Andreas Wagner, MD, Marc Ohlow, MD, Bernward Lauer, MD
Hubertus von Korn, MD, Jiangtao Yu, ...
Percutaneous angioplasty of aorto-coronary venous bypass grafts is associated with a higher incidence of adverse events compared to interventions in native vessels.1 Reasons for this well-known phenomen are emboli of pieces of friable...
Percutaneous angioplasty of aorto-coronary venous bypass grafts is associated with a higher incidence of adverse events compared to interventions in native vessels.1 Reasons for this well-known phenomen are emboli of pieces of friable...
Percutaneous angioplasty of...
08/01/2008
Journal of Invasive Cardiology
Predictors of In-hospital and 30-day Complications of Peripheral Vascular Interventions Using Bivalirudin as the Primary Anticoa
08/01/2008
Nicolas W. Shammas, MS, MD, David Allie, MD, Patrick Hall, MD, John Young, MD, John Laird, MD, Robert Safian, MD, Ajay Virmani, MD, on behalf of the APPROVE Investigators
Nicolas W. Shammas, MS, MD, David Al...
Predictors of complications in peripheral percutaneous interventions (PPI) with bivalirudin as a base anticoagulant have not yet been defined. The Angiomax Peripheral Procedure Registry of Vascular Events (APPROVE)1 offers a unique...
Predictors of complications in peripheral percutaneous interventions (PPI) with bivalirudin as a base anticoagulant have not yet been defined. The Angiomax Peripheral Procedure Registry of Vascular Events (APPROVE)1 offers a unique...
Predictors of complications in...
08/01/2008
Journal of Invasive Cardiology
Bailout Use of Platelet Glycoprotein IIb/IIIa Inhibition During Coronary Stent Implantation: Observations from the ESPRIT Trial
08/01/2008
Warren J. Cantor, MD,1 Mina Madan, MD,2 J. Conor O’Shea, MD,3 Robert J. Chisholm, MD,1 Henry K. Lui, MD,4 David J. Cohen, MD,5 Robert L. Feldman, MD,6 Robert Green, MD,7 Anne S. Hellkamp, PhD,3 Michael M. Kitt, MD,8 James E. Tcheng, MD3
Warren J. Cantor, MD,1 Mina Madan, M...
Potent inhibition of platelet aggregation during percutaneous coronary intervention (PCI) using intravenous antagonists of the platelet glycoprotein (GP) IIb/IIIa receptor results in a significant and sustained reduction in the occurrence of...
Potent inhibition of platelet aggregation during percutaneous coronary intervention (PCI) using intravenous antagonists of the platelet glycoprotein (GP) IIb/IIIa receptor results in a significant and sustained reduction in the occurrence of...
Potent inhibition of platelet...
08/01/2008
Journal of Invasive Cardiology
Coronary Angiography with Flat Panel Digital Detectors Significantly Increases the Sensitivity for Calcium Detection in Relation
08/01/2008
Jose M. de la Torre Hernandez, MD, Fermin Sainz Laso, MD, Cristina Ruisanchez, MD, Javier Zueco, MD, Alvaro Figueroa, MD, Thierry Colman, MD
Jose M. de la Torre Hernandez, MD, F...
Coronary calcification is an important process of atherosclerosis and represents advanced coronary disease.1,2 The presence and extent of coronary calcification is an important determinant of the outcome of percutaneous intervention...
Coronary calcification is an important process of atherosclerosis and represents advanced coronary disease.1,2 The presence and extent of coronary calcification is an important determinant of the outcome of percutaneous intervention...
Coronary calcification is an...
08/01/2008
Journal of Invasive Cardiology
Feature
Intracoronary Imaging with Optical Coherence Tomography after Cutting Balloon Angioplasty for In-stent Restenosis
08/01/2008
Shigenori Ito, MD, 1Makoto Itoh, MD, 2Takahiko Suzuki, MD
Shigenori Ito, MD, 1Makoto Itoh, MD, ...
Optical coherence tomography (OCT) represents a promising new technology1–2 for imaging the vascular microstructure at a level of 10–20 mm,3–6 which has not yet been achieved with the use of other imaging modalities.7–9 It may permit the...
Optical coherence tomography (OCT) represents a promising new technology1–2 for imaging the vascular microstructure at a level of 10–20 mm,3–6 which has not yet been achieved with the use of other imaging modalities.7–9 It may permit the...
Optical coherence tomography...
08/01/2008
Journal of Invasive Cardiology

Insights

Commentary
Evolving Use of Drug-eluting Stents in Diabetic Patients
08/01/2008
Kimberly A. Skelding, MD and John J. Young, MD
Kimberly A. Skelding, MD and John J. ...
There are more than 150 million adults worldwide estimated to have diabetes mellitus (DM), with Type 2 diabetes accounting for up to 95% of all cases.1 In 2001, the prevalence of DM in the United States was 8%, a relative increase of...
There are more than 150 million adults worldwide estimated to have diabetes mellitus (DM), with Type 2 diabetes accounting for up to 95% of all cases.1 In 2001, the prevalence of DM in the United States was 8%, a relative increase of...
There are more than 150 million...
08/01/2008
Journal of Invasive Cardiology

Advertisement

Advertisement

Advertisement

News

A study led by researchers from Shinshu University propose a simplified risk-scoring model helps clinicians assess when patients with cardiogenic shock can be safely weaned off from MCS devices, such as VA-ECMO or IMPELLA, using easily measurable health indicators like blood pressure and heart function. Credit Sho Suzuki from Shinshu University
Mechanical Circulatory Support
A Simple Risk Score for Weaning Patients From Mechanical Circulatory Support
10/23/2024
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu...
10/23/2024
Cath Lab Digest
The initial cases with the Luna TMVR System were conducted in Paraguay and the Republic of Georgia and supported by leading US structural heart experts and the Tioga Cardiovascular team.
Mitral Valve intervention
Tioga Cardiovascular Announces First-In-Human Cases With Its Luna Transcatheter Mitral Valve Replacement (TMVR) System
10/23/2024
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a...
10/23/2024
Cath Lab Digest
CABG
Black Patients More Likely to Die After Coronary Bypass Surgery
10/22/2024
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients,...
10/22/2024
Cath Lab Digest
Medaxiom survey
Cardiology Compensation and Production Reflect Post-Pandemic Changes to Provider Market
10/21/2024
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH,...
10/21/2024
Cath Lab Digest
Cardiology Innovations
Philips Showcases Next Level Cardiology Innovations for Improved Patient Care at TCT 2024
10/21/2024
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of...
10/21/2024
Vascular Disease Management
Cardiovascular Risk After MI
Prolocor Announces Publication of Confirmatory Results From Multicenter 800 Patient Study in the Journal of the American College of Cardiology (JACC)
10/21/2024
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold...
10/21/2024
Vascular Disease Management
Pharmaceuticals
Acticor Biotech Repositions Glenzocimab in the Treatment of Myocardial Infarction
10/21/2024
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b,...
10/21/2024
Cath Lab Digest
PVD
Yale Study Finds Link Between Eczema and Peripheral Vascular Disease
10/21/2024
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred...
10/21/2024
Cath Lab Digest
plaque analysis
HeartFlow Announces New Category I CPT Code from the American Medical Association for AI-Enabled Plaque Analysis to Assess Risk for Coronary Artery Disease
10/18/2024
“We commend the AMA’s issuance of this upgraded Category I CPT billing code, which validates the technology’s clinical value in quantifying and characterizing plaque to help assess risk and personalize treatment for patients with coronary...
“We commend the AMA’s issuance of this upgraded Category I CPT billing code, which validates the technology’s clinical value in quantifying and characterizing plaque to help assess risk and personalize treatment for patients with coronary...
“We commend the AMA’s issuance...
10/18/2024
Cath Lab Digest
Hypertension
New Study Links Obesity to Elevated Hypertension Risk Among Young Middle Eastern Women
10/18/2024
“Young Middle Eastern women who are obese or overweight are facing a higher risk for the development of atherosclerotic cardiovascular disease and its associated risk factors like hypertension and Type Two diabetes,” said Mohammad Adnan Bani...
“Young Middle Eastern women who are obese or overweight are facing a higher risk for the development of atherosclerotic cardiovascular disease and its associated risk factors like hypertension and Type Two diabetes,” said Mohammad Adnan Bani...
“Young Middle Eastern women who...
10/18/2024
Cath Lab Digest

Advertisement

Advertisement

A study led by researchers from Shinshu University propose a simplified risk-scoring model helps clinicians assess when patients with cardiogenic shock can be safely weaned off from MCS devices, such as VA-ECMO or IMPELLA, using easily measurable health indicators like blood pressure and heart function. Credit Sho Suzuki from Shinshu University
Mechanical Circulatory Support
A Simple Risk Score for Weaning Patients From Mechanical Circulatory Support
10/23/2024
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu...
10/23/2024
Cath Lab Digest
Original Contribution
Intravascular Ultrasound in the Assessment of Coronary Artery Anomalies in Young Patients: A Tertiary Center Experience
10/23/2024
The authors describe a young population of patients with anomalous aortic origin of a coronary artery and myocardial bridge and review the safety of intravascular ultrasound in this population.
The authors describe a young population of patients with anomalous aortic origin of a coronary artery and myocardial bridge and review the safety of intravascular ultrasound in this population.
The authors describe a young...
10/23/2024
Journal of Invasive Cardiology
The initial cases with the Luna TMVR System were conducted in Paraguay and the Republic of Georgia and supported by leading US structural heart experts and the Tioga Cardiovascular team.
Mitral Valve intervention
Tioga Cardiovascular Announces First-In-Human Cases With Its Luna Transcatheter Mitral Valve Replacement (TMVR) System
10/23/2024
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a...
10/23/2024
Cath Lab Digest
Original Contribution
Comparison of Two Vascular Closure Device Strategies for Transfemoral Transcatheter Aortic Valve Replacement Using Suture-Based and Collagen-Plug-Based Techniques and Associated Vascular Complications
10/23/2024
The authors evaluated their experience with 2 distinct vascular closure device approaches using the Perclose ProGlide and the Angio-Seal, as well as the impact on vascular access site complications during transcatheter aortic valve...
The authors evaluated their experience with 2 distinct vascular closure device approaches using the Perclose ProGlide and the Angio-Seal, as well as the impact on vascular access site complications during transcatheter aortic valve...
The authors evaluated their...
10/23/2024
Journal of Invasive Cardiology
CABG
Black Patients More Likely to Die After Coronary Bypass Surgery
10/22/2024
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients,...
10/22/2024
Cath Lab Digest
Medaxiom survey
Cardiology Compensation and Production Reflect Post-Pandemic Changes to Provider Market
10/21/2024
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH,...
10/21/2024
Cath Lab Digest
Cardiology Innovations
Philips Showcases Next Level Cardiology Innovations for Improved Patient Care at TCT 2024
10/21/2024
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of...
10/21/2024
Vascular Disease Management
Cardiovascular Risk After MI
Prolocor Announces Publication of Confirmatory Results From Multicenter 800 Patient Study in the Journal of the American College of Cardiology (JACC)
10/21/2024
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold...
10/21/2024
Vascular Disease Management
Pharmaceuticals
Acticor Biotech Repositions Glenzocimab in the Treatment of Myocardial Infarction
10/21/2024
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b,...
10/21/2024
Cath Lab Digest
PVD
Yale Study Finds Link Between Eczema and Peripheral Vascular Disease
10/21/2024
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred...
10/21/2024
Cath Lab Digest

July 2005 Volume 17 Issue 7

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement